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The authors regret the omission of the simulated annealing omit electron density map for the DNA molecules, as shown below. The map and re-
finement of the DNA occupancy suggested that DNA may adopt multiple conformations, with the structures presented in the paper represent-
ing a major conformation. The re-refined structures with partial occupancy for the DNA molecules are deposited in the RSCB Protein Data 
Bank (4OI7 and 4OI8). This does not alter the main conclusion of the paper, which is supported by combined structural and functional data.
Figure 11. The top and bottom panels show stereo views of the simulated annealing omit 2Fo-Fc electron density map for 
4OI7 and 4OI8, respectively, contoured at 0.8 s, calculated after refinement devoid of DNA. The RAGE molecules are shown as 
silver ribbons, and the DNA molecules as magenta sticks. 
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Infection and tissue damage cause an immediate 
inflammatory response that is characterized by 
the activation of innate immune cells and other 
local stromal cells, followed by rapid recruit-
ment of additional immune cells to the affected 
site. This response serves to control the invading 
pathogen and to initiate reparative processes that 
restore tissue function. Certain surface-exposed 
immune receptors recognize several lipidated or 
proteinaceous activators that are foreign to the 
host, such as lipopeptides (TLR2), LPSs (TLR4), 
and flagellin (TLR5). In contrast, all nucleic 
acid–sensing immune receptors described to date 
are expressed in endolysosomal compartments 
(TLR3, TLR7–9; Takeda et al., 2003) or in the 
cytosol (RIG-I family members, AIM2, IFI16, 
and others; Hornung and Latz, 2010; Ranjan 
et al., 2009), and thus are sequestered away from 
the extracellular milieu. This internal location 
of nucleic acid sensing receptors has been pro-
posed to limit receptor triggering by self-nucleic 
acids that are present in the extracellular space 
under homeostatic conditions. Indeed, experi-
mental mislocalization of TLR9, a nonredun-
dant endosomal signaling receptor for DNA, to 
the plasma membrane led to the recognition of 
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Recognition of DNA and RNA molecules derived from pathogens or self-antigen is one way 
the mammalian immune system senses infection and tissue damage. Activation of immune 
signaling receptors by nucleic acids is controlled by limiting the access of DNA and RNA to 
intracellular receptors, but the mechanisms by which endosome-resident receptors encoun-
ter nucleic acids from the extracellular space are largely undefined. In this study, we show 
that the receptor for advanced glycation end-products (RAGE) promoted DNA uptake into 
endosomes and lowered the immune recognition threshold for the activation of Toll-like 
receptor 9, the principal DNA-recognizing transmembrane signaling receptor. Structural 
analysis of RAGE–DNA complexes indicated that DNA interacted with dimers of the outer-
most RAGE extracellular domains, and could induce formation of higher-order receptor 
complexes. Furthermore, mice deficient in RAGE were unable to mount a typical inflamma-
tory response to DNA in the lung, indicating that RAGE is important for the detection of 
nucleic acids in vivo.
© 2013 Sirois et al. This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial– 
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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expressing RAGE (Fig. 1 B). These data suggested that RAGE 
interacts with and concentrates DNA on cell surfaces.
We next sought to identify the characteristics of RAGE-
binding nucleic acids. Several structural classes of CpG oligo-
nucleotides, which are known to activate TLR9 (Vollmer et al., 
2004), bound to purified RAGE protein with low nanomolar 
apparent affinities (Fig. 1 C). Notably, oligodeoxynucleotides 
(ODN) bound RAGE in a sequence-independent manner, as 
even phosphodiester and phosphorothioate sugar-phosphate 
backbones without nucleotide bases bound to RAGE with 
apparent high affinities (Fig. 1 D). Similarly, deoxyribose was 
not required for nucleic acid interaction with RAGE, as 
both phosphodiester and phosphorothioated RNA oligo-
nucleotides also bound in the low nanomolar range (Fig. 1 E). 
RAGE was able to bind ODN as short as 15 nt in length 
(Fig. 1 F), and we observed similar binding affinities for 
single-stranded (ss) and double-stranded (ds) forms of DNA 
(Fig. 1, G and H). These studies indicated that RAGE may bind 
to multiple forms of nucleic acids by interaction with the sugar-
phosphate backbones.
RAGE binds DNA through electrostatic  
attractions with the backbone
The RAGE extracellular region is composed of three struc-
tural domains named according to their homology with other 
members of the immunoglobulin superfamily: an N-terminal 
variable-type (V; or I-type; Koch et. al. 2010) domain, followed 
by two membrane-proximal constant-type domains (C1 and C2). 
The V and C1 domains are thought to form a single structural 
unit, which is separated from the C2 domain by a flexible linker 
region (Dattilo et al., 2007). To assess which part of RAGE inter-
acts with DNA, we investigated DNA binding to recombi-
nant V domain, V-C1 domains, or C1-C2 domains, respectively. 
DNA binding was mediated primarily by the outermost 
V domain of RAGE (Fig. 2 A), similar to what has been re-
ported for binding of other RAGE ligands (Allmen et al., 
2008; Dattilo et al., 2007; Park and Boyington, 2010). The C2 
domain did not directly bind DNA in our assays (Fig. 2 A).
We next determined the crystal structures of the RAGE 
V-C1 domain in complex with a 22-nt dsDNA derived from 
vaccinia virus genomic repeat sequences and a 22mer CpG 
motif-containing dsDNA, at resolutions of 2.8 and 3.1 Å, re-
spectively (Table 1). As the structures were essentially the same 
except for the two dsDNA sequences, this study will focus on 
the higher resolution 2.8-Å structure. The double-stranded 
oligomer used for crystallization bound to RAGE in a manner 
similar to single-stranded CpG-B (Fig. 1 H). The structures 
were solved by molecular replacement using two previously 
published RAGE V-C1 domain structures (PDB accession nos. 
3CJJ [Koch et al., 2010] and 3O3U [Park and Boyington, 2010]) 
as the search models. The structures revealed that the RAGE 
V-C1 domain formed a homodimer with the dsDNA bound in 
a concave cradle near the dimer interface (Fig. 2 B). The two 
V-C1 monomers interacted with each other in a dyad con-
figuration with their V domains located at the dimer interface 
(Fig. 2 B), creating an extensive positively charged pocket where 
self-DNA from the extracellular environment (Barton et al., 
2006). At the same time, endosomal localization of TLR9 is 
required for efficient recognition of viral DNA, suggesting 
that nucleic acids become concentrated in endosomal com-
partments or that additional mechanisms of receptor process-
ing are required for nucleic acid recognition in the endosome 
(Ewald et al., 2008, 2011; Park et al., 2008).
Along with compartmentalization, other safeguards typi-
cally prevent self-nucleic acid recognition by innate immune 
receptors. For instance, digestion of DNA by extracellular and 
intracellular nucleases ensures that self-DNA released under 
normal conditions escapes detection by nucleic acid sensors 
(Napirei et al., 2000; Evans and Aguilera, 2003; Kawane et al., 
2010). However, if nucleic acid concentrations exceed the 
nuclease capacity, such as during infections or in situations 
of increased cell damage, signaling receptors and their down-
stream inflammatory effects can be triggered. Chronic activa-
tion of inflammatory responses by nucleic acids can result in 
undesirable autoimmune syndromes and dramatic pathologies 
(Crow and Rehwinkel, 2009; Horton et al., 2010), yet the rec-
ognition of DNA during tissue destruction is an integral part 
of the host immune and repair responses (Gregorio et al., 2010). 
Hence, effective management of self-tolerance and damage 
sensing appears to require the coordinated delivery of extra-
cellular DNA to intracellular sites of recognition.
We were interested in defining cell surface receptor pro-
teins that interact with extracellular nucleic acids. Here, we 
identify that the receptor for advanced glycation end-products 
(RAGE) binds directly to DNA and RNA and promotes their 
uptake into cells. RAGE can thereby sensitize cells to extra-
cellular nucleic acids. A co-crystal structure of RAGE with 
DNA supports the concept that RAGE binds to nucleic acids 
via interaction with the charged sugar-phosphate backbones 
in a sequence-independent manner. While other receptors also 
play roles in nucleic acid recognition by immune cells, RAGE 
deficiency largely prevents an inflammatory response toward 
TLR9-stimulatory DNA in the lungs, suggesting that RAGE 
plays an important role in the control of immune responses to 
DNA in vivo.
RESULTS
RAGE promotes DNA binding and uptake by cells  
and interacts with DNA in a sequence-independent manner
To address the role of RAGE in cellular responses to DNA, we 
generated cell lines expressing chimeric fluorescent RAGE 
driven by a tetracycline-inducible promoter. Uninduced cells did 
not show significant RAGE expression, and we observed only 
a low amount of DNA binding to the cells (Fig. 1 A). RAGE-
mCitrine expression was 100-fold higher after promoter 
induction, and RAGE-expressing cells bound 10–100-fold 
more fluorescently labeled DNA compared with uninduced 
cells (Fig. 1 A). In addition, the amount of DNA binding cor-
related directly with the level of RAGE expression (Fig. 1 A). 
Notably, when incubated with fluorescently labeled DNA 
and visualized by confocal microscopy, cells expressing RAGE 
had visibly more DNA bound at the cell surface than cells not 
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Close examination of the protein–DNA interaction surface 
indicated that 7 positively charged residues on each V-C1 
unit were in close proximity to the negatively charged DNA 
backbone, spanning 17 bp (Fig. 3, A and B), in agreement 
with our finding that the minimal length requirement for 
DNA binding was 15 bases (Fig. 1 F). A total of 1300 Å2 of 
solvent accessible surface area was buried at the RAGE–DNA 
interface. There are two DNA-binding patches on each RAGE 
molecule, hereafter referred to as “site 1” and “site 2” (Fig. 3 A). 
Site 1 is located entirely in the V domain near -strand B (B), 
and the connecting loops containing residues K37, K39, and 
K43, as well as K107 from -strand G. Notably, residues K43 
from molecule A and R29 from molecule B coordinate the 
same water molecule (w26) that forms a hydrogen bond with 
an oxygen of the DNA phosphate backbone (Fig. 3 A, top 
right). Site 2 is located at the juncture of the V and C1 domains, 
dsDNA binds. Excellent charge and shape complementarity 
were observed between the RAGE interface and the bound 
dsDNA. Each of the RAGE V-C1 domains engage both strands 
of the dsDNA through basic or hydrophilic residues from 
RAGE interacting with oxygen atoms of the DNA backbone 
and, in some cases, through coordinating water molecules. In 
contrast to sequence-specific DNA recognition by proteins 
such as transcription factors, the current structures showed no 
contact between RAGE and the nucleotide bases. Because 
the overall negative charge on the DNA molecule is deter-
mined by its phosphate backbone, we tested whether cationic 
polymer polyethyleneimine (PEI) could compete with RAGE 
for DNA binding. Our results showed that PEI could “mask” 
the negative charge of DNA and was sufficient to negate 
DNA–RAGE binding in vitro (Fig. 2 C), further highlighting 
the electrostatic nature of the recognition.
Figure 1. RAGE binds directly to nucleic 
acid ligands on the cell surface and pro-
motes their uptake. (A) 293T cells expressing 
tetracycline-inducible RAGE-mCitrine were 
left uninduced (left, black population) or 
treated to induce RAGE expression (right, 
black population) and then incubated on ice 
with 1 µM Alexa Fluor 647–labeled ODN 2336 
(CpG-A, red populations), washed, and ana-
lyzed by flow cytometry. Data are representa-
tive of three similar experiments. (B) HeLa 
cells expressing Rab 4a-YFP (red) to stain 
cytoplasmic structures, with or without coex-
pression of RAGE-YFP (green), were incubated 
with 1 µM Alexa Fluor 647–labeled ODN 2336 
(CpG-A, blue) for 5 min. Unbound DNA was 
washed away and live cells were imaged  
by confocal microscopy. Image is representa-
tive of four similar experiments. Bar, 5 µm. 
(C–H) Ability of purified, His-tagged human 
RAGE extracellular domain to bind to biotiny-
lated oligonucleotide ligands in solution was 
assessed by AlphaScreen homogenous binding 
assay. Indicated concentrations of biotinylated 
ODNs or oligoribonucleotides (ORN) were 
incubated with 40 nM RAGE (V-C1-C2)-6His. 
PO, phosphodiester-linked deoxyribose back-
bone; PS, phosphorothioate-linked deoxyri-
bose backbone. Data shown are representative 
of three or more independent experiments. 
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RNA. This is consistent with the dominant presence of flexi-
ble lysine and arginine residues at the DNA-binding surface.
To probe the importance of the two DNA-binding 
regions, we generated mutations in key binding residues. 
Mutating either the site 1 (mutant 1) or site 2 (mutant 2) sur-
faces compromised DNA binding, whereas mutating three 
basic residues outside the DNA-binding surface (mutant 0) 
had no effect (Fig. 3 D). This confirmed that both site 1 and 
site 2 near the RAGE V-C1 dimer interface are critical for 
DNA binding.
and includes residues R29 at the C terminus of A, Y118, and 
K123 of the V-C1 linker, and R216 and R218 of G in the 
C1 domain. The amide group of R218 forms a direct hydro-
gen bond with a backbone oxygen of DNA (Fig. 3 A, bottom 
right). The footprints of the two RAGE molecules on the 
dsDNA are very similar, but not identical (Fig. 3 C), with the 
dsDNA switching its location of the major and minor grooves 
relative to the RAGE molecules, suggesting a rather flexible 
surface of the RAGE dimer that may be able to accommo-
date various forms of nucleic acids, such as ds or ss DNA and 
Figure 2. DNA interacts with a region of positive charges at the RAGE dimer interface. (A) Binding in solution of biotinylated ODN 2006  
(CpG-B) to His-tagged full length human RAGE extracellular domain (V-C1-C2-His) or isolated structural domains was evaluated by AlphaScreen homog-
enous binding assay. Indicated concentrations of CpG-B were incubated with 40 nM RAGE. Data shown are from one experiment representative of three 
independent experiments. (B) Electrostatic charge surface of RAGE is shown on a scale of 10 kT/e (red) to +10 kT/e (blue) in three different orientations. 
The bound dsDNA is shown as an orange ribbon. (C) Polyethyleneimine (PEI) was incubated together with RAGE and biotinylated CpG DNA, as indicated, 
and RAGE–DNA interaction was assessed by AlphaScreen assay (PO, phosphodiester and PS, phosphorothioate backbones), CpG-A, and CpG-C. Data 
shown are from one experiment representative of two independent experiments.
JEM Vol. 210, No. 11 
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and smaller in size. Unexpectedly, examination of the 3CJJ 
crystal lattice packing revealed that the trans dimers are also 
present in this crystal (Fig. 4 A), though the DNA-binding 
site is occluded by crystallographic symmetry mates. It is thus 
clear that the trans dimer formation is independent of DNA 
binding, and both the trans and the cis dimers can coexist as 
in the 3CJJ crystal. This is consistent with our observation 
that the most intense fluorescence of RAGE on the cell sur-
face is located at the juncture of two adjacent cells (see Fig. 5 D), 
indicating that both trans and cis dimerization may be in-
volved in the formation of the RAGE oligomers, with the cis 
and trans configurations mediating RAGE interaction on the 
same cell and adjacent cells, respectively.
The chemical nature of the trans dimerization interface, 
including a typical buried solvent-accessible surface area 
of 1,100 Å2, together with the observations that RAGE V 
(Ostendorp et al., 2007), V-C1 (Koch et al., 2010), or V-C1-C2 
(Srikrishna et al., 2010; Sárkány et al., 2011) domains sponta-
neously dimerize in solution, suggests that the V-domain– 
mediated dimers are likely to be present under physiological 
conditions. RAGE molecules are highly conserved in both 
their DNA-binding sites and dimerization sites, and thus 
RAGE dimer binding to nucleic acids through electrostatic 
attraction may be a common mode of its function across dif-
ferent species.
DNA can induce formation of higher-order RAGE oligomers
To confirm RAGE dimer formation in live cells, we sub-
jected 293T cells expressing full-length human RAGE-mCit-
rine to treatment with the cell-impermeable cross-linking 
agent BS3, followed by cell lysis, protein denaturation, and gel 
electrophoresis. In the presence of cross-linker, higher molec-
ular weight bands corresponding to dimers and higher-order 
oligomers can be detected in unstimulated cells (Fig. 5 A). To 
further explore the relationship of native RAGE dimers with 
DNA ligands, HEK293 cell lines stably expressing RAGE 
tagged with FRET donor (CFP or mCerulean) and acceptor 
(YFP or mCitrine) fluorophores were analyzed by both flow 
cytometry and confocal microscopy for sensitized emission 
Förster resonance energy transfer (FRET) between the fluor-
escent protein tags. A constitutive baseline energy transfer 
was observed in unstimulated cells (Fig. 5, B and D, top), sup-
porting the idea that RAGE exists as a dimer in the absence 
of ligand. Addition of a CpG-B 72-mer (Fig. 5 C) or 24-mer 
oligonucleotide (Fig. 5 D, middle) did not alter energy trans-
fer efficiency. Interestingly, however, the addition of a CpG-A 
21-mer induced a dose-dependent increase in FRET effi-
ciency (Fig. 5 C). CpG-A oligonucleotides are able to form 
large complexes in solution by virtue of G-tetrad association 
between poly-G tails on the ends of the ODN (Dapić et al., 
2003). The induced increase in FRET is consistent with 
higher-order RAGE oligomer formation. In keeping with 
this observation, CpG-A DNA can be seen to induce aggre-
gation of RAGE into clusters on the cell surface (Fig. 5 D, 
bottom), which is not observed in unstimulated cells or cells 
incubated with CpG-B (Fig. 5 D, top and middle). Notably, 
No major conformational changes were observed in the 
RAGE V-C1 domains between the DNA-bound structures 
and those of the non-DNA bound forms (3CJJ [Park and 
Boyington, 2010] and 3O3U [Koch et al., 2010]; Fig. 4 A), 
consistent with the observation that the linkage between the 
V and C1 domains is fairly rigid (Dattilo et al., 2007) and is 
likely not modified by the binding of DNA ligands.
Dimerization of the RAGE V-C1 domains
A hydrophobic surface on the V domain is located at the cen-
ter of the RAGE dimer interface in the current configuration 
we call “trans.” It is composed of residues L79, P80, F85, P87, 
and A88 from the E strand and the connecting loops, plus 
P33 and V35 from the B strand, and P45 and P46 from the 
B-C loop (Fig. 4, A and B). The hydrophobic patch is sur-
rounded by hydrophilic residues decorating the circumference 
of the dimer interface. A previous structure of RAGE V-C1 in 
the absence of bound DNA showed a crystallographic C1-C1 
dimer that we call “cis,” which is centered at a bound zinc ion 
(Koch et al., 2010). In comparison with the V domain-centered 
trans dimer interface, the cis dimer interface is hydrophilic 
Table 1. X-ray crystallography data collection  
and refinement statistics
Data collection I (752-753, VV) II (981-982, CpG)
Spacegroup P61 P61
Unit cell (a, b, c) (Å) 79.12, 79.12, 224.04 77.92, 77.92, 224.39
(a, , g) (°) 90, 90, 120 90, 90, 120
Wavelength (Å) 1.00 1.00
Resolution (last shell) (Å) 50–2.80 (2.85–2.80) 50–3.10 (3.15–3.10)
No of reflections (total/
unique)
154198/19330 138765/13817
Completeness (last shell) 
(%)
99.4 (96.6)a 99.0 (85.6)a
I/s(I) (last shell) 14.49 (1.97)a 16.10 (1.97)a
Rmerge (last shell) (%)b 10.7 (60.7)a 14.0 (65.3)a
Refinement
Number of protein atoms 3,267 3274
No. of DNA base pairs 22 22
No. of solvent/hetero-
atoms
75 61
Rmsd bond lengths (Å) 0.007 0.008
Rmsd bond angles (°) 0.982 0.975
Rwork (%)c 19.6 19.1
Rfree (%)d 23.8 23.1
Ramachandran plot 
favored/disallowed (%)e
95.7/0 95.7/0
PDB accession code 3S59 3S58
aAsterisked numbers correspond to the last resolution shell.
bRmerge = ∑h ∑i |Ii(h) -<I(h)> | / ∑h∑i Ii(h), where Ii(h) and <I(h)> are the ith and mean 
measurement of the intensity of reflection h.
cRwork = ∑h||Fobs (h)|-|Fcalc (h)|| / ∑h|Fobs (h)|, where Fobs (h) and F calc (h) are the 
observed and calculated structure factors, respectively. No I/⌠ cutoff was applied.
dRfree is the R value obtained for a test set of reflections consisting of a randomly 
selected 5% subset of the data set excluded from refinement.
eValues from Molprobity server (http://molprobity.biochem.duke.edu/).
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RAGE. In addition to the increased DNA binding to the 
cell surface observed previously, (Fig. 1, A and B; and Fig. 6 A, 
4°C), RAGE-expressing cells also showed a notable increase 
in total DNA uptake over a 30-min time period (Fig. 6 A, 
37°C), compared with cells not expressing RAGE. This ef-
fect was DNA specific, as binding and uptake of transferrin 
to its receptor (Fig. 6 A) or the uptake of TLR2 ligand (not 
depicted) was not influenced by RAGE expression. Hence, 
RAGE increases the interaction of cells with nucleic acids 
and promotes their uptake.
CpG DNA in cell culture medium gains access to endo-
somal compartments, where it is able to interact with and stim-
ulate Toll-like receptor 9 (TLR9), although the mechanism by 
streptavidin complexation of a relatively long biotinylated ODN 
also increased FRET efficiency (Fig. 5 C). These findings sug-
gest that whereas RAGE may bind DNA indiscriminately, 
larger ligand complexes can induce receptor reorganization 
on the cell surface.
RAGE expression promotes DNA uptake  
by cells via the endosomal route
Having established that RAGE and DNA interact at the cell 
surface, we sought to understand the functional consequences 
of this interaction. To assess whether interaction with RAGE 
influenced uptake of oligonucleotides into the cell, we evaluated 
the total uptake of fluorescent ODN in cells with or without 
Figure 3. Details of the RAGE–DNA binding interface. (A) Surface representation (center) showing positively charged residues lining the RAGE 
dimer interface where DNA binding occurs. DNA-binding residues are colored green on one RAGE molecule (“A”) and cyan on the other (“B”). Side panels 
show the molecular details of the two discrete binding sites, indicated by red boxes, for each RAGE V-C1 domain colored green and cyan. Hydrogen bonds 
are indicated with dotted lines, and the two strands of the dsDNA are colored silver and yellow, respectively. (B) Footprint of RAGE on dsDNA colored 
cyan and green for each of the V-C1 domains, as in A. (C) The two RAGE V-C1 molecules (cyan and green) in the crystal are superimposed with their 
bound dsDNA (blue and green), showing the switched positions for the major and minor grooves of the dsDNA in reference to the V-C1 domains. (D) 
Fluorescence polarization analysis of proteins containing mutations in site 1 (mutant 1) and site 2 (mutant 2) and mutations outside of the DNA-binding 
surface (mutant 0).
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RAGE increases TLR9-dependent responses  
to suboptimal DNA stimuli
Both RAGE and TLR9 have been shown to activate the 
NF-B family of transcription factors upon ligation of stim-
ulatory ligands (Chuang and Ulevitch, 2000; Yan et al., 1994). 
To assess the ability of CpG DNA to activate RAGE signaling, 
we used an HEK cell line expressing a luciferase reporter 
gene under the control of an NF-B–inducible promoter. No 
change in reporter activation was observed upon DNA stimu-
lation when these cells overexpressed RAGE alone (unpub-
lished data). To evaluate the ability of RAGE to contribute to 
TLR9-dependent responses to DNA, cell lines stably express-
ing either TLR9 or TLR7 were transiently transfected with 
the NF-B luciferase reporter and either RAGE or RAGE 
lacking the putative cytoplasmic signaling domain (RAGE-dC). 
Both cell lines expressed similar levels of the two RAGE 
constructs (Fig. 7 A) and showed similar responses to con-
trol stimuli (Fig. 7 A, bar graphs). CpG-B oligonucleotides 
preferentially activate the transcription factor NF-B down-
stream of TLR9 in many cell types, whereas CpG-A ODNs 
optimally induce type I interferons and do not induce a strong 
NF-B response. CpG-B activated NF-B in a dose-responsive 
manner in cells expressing TLR9 without RAGE, and this ac-
tivation was notably enhanced when cells coexpressed RAGE 
or RAGE-dC (Fig. 7 A, top). This RAGE-dependent en-
hancement was specific for DNA activation of TLR9, as no 
which this uptake occurs is unknown. Although cellular up-
take of DNA is not strictly RAGE dependent (Fig. 6 A), we 
sought to evaluate the nature of the receptor–ligand associa-
tion after surface binding. We stably expressed fluorescently 
tagged RAGE together with fluorescently tagged endosomal 
markers and assessed the binding and trafficking of DNA in 
live cells. Fluorescently labeled DNA was seen to associate 
with RAGE at the cell surface and traveled together with the 
receptor into both early and late endosomal compartments 
(Fig. 6, B and C). Although not all DNA-positive endosomes 
were RAGE-positive at a given time point, RAGE and DNA 
appeared to remain associated during uptake and progression 
through the endosomal network. Furthermore, our data sug-
gest that this association may be more prevalent for CpG-A 
than CpG-B, which is consistent with the higher affinity of 
CpG-A observed in binding assays (Fig. 1 C). To more explicitly 
address whether RAGE might interact with TLR9 after up-
take, we assessed the ability of TLR9 to co-immunoprecipitate 
RAGE from lysates of cells before and after exposure to 
TLR9-stimulatory DNA. We saw that TLR9 associated with 
a relatively small but notable amount of RAGE in unstimu-
lated cells and that this association was enhanced after stimu-
lation of the cells with CpG DNA (Fig. 6 D). This supports 
the idea that RAGE-associated DNA is delivered to TLR9-
containing compartments and suggests that these receptors 
may interact simultaneously with a common ligand.
Figure 4. RAGE dimers form in two ori-
entations. (A) Ribbon diagrams of the RAGE 
V-C1 dimerization interface. Left, RAGE V-C1 
crystal packing in the non-DNA–bound form 
(3CJJ; Koch et al., 2010), with V-C1 monomers 
colored yellow, orange, and wheat. The orange 
sphere indicates a zinc ion. Middle, wheat, 
and orange V-C1 domains from the left super-
imposed onto the V-C1 domains (cyan and 
green) in the current DNA-bound crystal 
structure. The dimer interface at the V domain 
(red circle) is represented in gray surface 
(right), with the hydrophobic and hydrophilic 
residues colored orange and green, respec-
tively. (B) The RAGE dimer interface centered 
at the V domain. Residues involved in RAGE 
dimerization are shown as sticks and colored 
cyan and green as the respective molecules. 
Water molecules are shown as red spheres 
and hydrogen bonds as dotted lines. The crys-
tallographic dimer from 3CJJ is superimposed 
in our DNA-bound RAGE dimer structure in 
wheat and orange.
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similar levels of association with CpG DNA by confocal micros-
copy. Collectively, these data demonstrate that RAGE enhances 
NF-B activation by CpG-DNA in a TLR9-dependent fash-
ion, and that RAGE promotes increased delivery of ligand to 
TLR9 in this system, rather than activating the NF-B path-
way through its own signaling domain.
We next sought to understand whether RAGE could simi-
larly affect responses to autoimmune disease–relevant nucleic 
NF-B activation was observed in cells coexpressing RAGE 
and TLR7 (Fig. 7 A, bottom). To further evaluate the role of 
the signaling domain in RAGE-dependent responses to DNA, 
we studied 293T cells expressing RAGE or RAGE-dC under 
the control of a tetracycline-inducible promoter. Cells express-
ing full-length or tail-truncated RAGE internalized more 
CpG-A and CpG-B over a 2-h period than their uninduced 
counterparts (Fig. 7 B), and both forms of RAGE showed 
Figure 5. Constitutive RAGE dimers form higher order oligomers in the presence of complex DNA ligands. (A) 293T cells expressing RAGE-mCitrine 
were incubated with or without the amine-reactive cross-linking agent BS3 before immunoblot for the mCitrine tag. Data shown are representative of 
three independent experiments. (B) HEK293 cells coexpressing RAGE-CFP and RAGE-YFP were analyzed for FRET by flow cytometry. Cells show detectable 
baseline FRET (black histogram) in the absence of ligand. Cells expressing only RAGE-CFP (FRET-negative, gray histogram) are shown for reference. Data 
shown are representative of more than five independent experiments. (C) Cells from (B) were incubated with the indicated concentrations of oligonucleo-
tides and analyzed for FRET by flow cytometry. Graph shows the percent increase in FRET signal over baseline FRET. “x2” indicates biotinylated ODN 
complexed with streptavidin in a 2:1 ratio. Data are representative of two independent experiments. (D) HEK293 cells coexpressing RAGE-mCerulean and 
RAGE-mCitrine were incubated for 30 min at 37°C with Alexa Fluor 647–labeled CpG-A or CpG-B and analyzed for FRET by confocal microscopy. Images 
are representative of four independent experiments. Bars, 5 µm. Data in right panel are shown as mean and distribution of quantified cells from the rep-
resentative experiment.
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cells expressing RAGE (Fig. 8 A, left, closed bars). When the 
extracellular DNA and RNA content was removed by addi-
tion of benzonase to the supernatants, the RAGE-mediated 
increase in NF-B activity in the reporter cells was reduced 
to background levels (Fig. 8 A, left, open bars). This indi-
cates that the enhancement of TLR9 activation by RAGE 
is largely caused by recognition of nucleic acids, rather than 
acids such as mammalian DNA. For this, the luciferase re-
porter cell line was co-cultured with immortalized murine 
bone marrow–derived macrophages, which were treated with 
silica to induce macrophage cell death and nucleic acid re-
lease (Hornung et al., 2008). Indeed, the presence of silica-
killed macrophages in co-culture activated NF-B in the 
luciferase reporter cell line, and this activation increased in 
Figure 6. RAGE promotes cellular DNA 
uptake into endosomes. (A) 293T cells ex-
pressing tetracycline-inducible RAGE-mCitrine 
were induced overnight (black bars) or left 
untreated (white bars), and then incubated 
with 1 µM Alexa Fluor 647–labeled ODN 2336 
(CpG-A), ODN 2006 (CpG-B) or transferrin for 
30 min, either on ice or at 37°C to permit 
receptor-mediated uptake. Cells were washed 
and fluorescence was assessed by flow cy-
tometry. Data are from one experiment repre-
sentative of three. (B and C) HeLa cells 
expressing RAGE-CFP (green) and the early 
endosome protein Rab 5a-RFP (B; red) or the 
late endosome protein Rab 9a-YFP (C; red) 
were incubated with 1 µM Alexa Fluor 647–
labeled CpG-A or CpG-B (blue) for 5 min, 
washed to remove unbound DNA, and then 
incubated for 20 min at 37°C before analysis 
by confocal microscopy. Line analyses show 
pixel intensity (y axis) along the indicated line 
(x axis) in each of the three fluorescence 
channels. Images are representative of 4–5 
quantified fields in this experiment, and a 
total of four independent imaging experi-
ments. Bars, 5 µm. (D) Cells expressing TLR9-
YFP with or without coexpressed RAGE were 
stimulated with CpG-B for 1 h or left un-
treated and TLR9 was subsequently immuno-
precipitated using an anti-GFP antibody. TLR9 
and coimmunoprecipitated RAGE were as-
sessed by Western blot using specific antibod-
ies. Cell lysates were controlled for TLR9 and 
RAGE total expression (Input). * indicates an 
IP condition with beads but no antibody, to 
identify nonspecific binding; ns indicates a 
nonspecific band. Data are representative of 
three similar experiments.
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Figure 7. RAGE increases TLR9-dependent NF-B activation in response to DNA ligands. (A) HEK293 cells stably expressing TLR9 or TLR7 were tran-
siently transfected with an NF-B–driven luciferase reporter and wild-type RAGE, RAGE lacking the cytoplasmic domain (RAGE dC), or empty vector (control). 
Cells were stimulated as indicated for 20 h before luciferase assay readout. Data are shown as mean ± SEM for duplicate samples and are representative of four 
similar experiments. Expression levels of RAGE and RAGE dC in concurrently transfected, unstimulated cells was assessed by Western blot (right). (B) 293T cells 
expressing tetracycline-inducible constructs of mCitrine-tagged RAGE, RAGE dC, or empty vector control were left untreated (-dox) or treated with doxycycline to 
induce construct expression (+dox). Cells were treated for the indicated times with fluorescently labeled CpG-A or CpG-B and washed to remove excess oligo-
nucleotides, and fluorescence was analyzed by flow cytometry. Plots show background-corrected median fluorescence intensities corresponding to labeled CpG, 
normalized to the signal from untreated HEK 293T cells without exogenous RAGE-expression. Error bars represent SEM for two independent experiments. P-value 
indicates significance in unpaired Student’s t test. (C) Cells from B were induced with doxycycline and treated with fluorescently labeled CpG-A, and localization 
of ligand and receptor was assessed at the indicated time points. Data shown are representative of two independent experiments. Bars, 5 µm.
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intranasal CpG DNA administration (data not depicted); how-
ever, the absence of sRAGE may also be a factor in the knock-
out phenotype. Although these complexities remain to be 
elucidated, the data presented here indicate that RAGE ex-
pression plays an important role in mediating inflammatory 
response to immunostimulatory DNA in vivo, and particu-
larly, in the lung.
DISCUSSION
RAGE has been implicated in initiating and perpetuating in-
flammatory responses upon engagement of glycated proteins, 
amyloid- fibrils, S100 proteins, and HMGB1 (Hofmann et al., 
1999; Hudson et al., 2008; Huttunen et al., 1999; Lander et al., 
other components of cell debris. In effect, DNA from dying 
macrophages appeared to interact with fluorescently tagged 
RAGE when co-cultured cells were imaged by confocal 
microscopy (Fig. 8 B) and RAGE expression led to increased 
uptake of DNA from the co-cultured dying cells (not de-
picted). Collectively, the data in Figs. 7 and 8 suggest that 
RAGE effectively delivers DNA into the cellular compart-
ments in which TLR9 is activated and that expression of 
RAGE sensitizes cells to both synthetic and endogenous nu-
cleic acids present in the extracellular environment.
RAGE-deficient mice have impaired  
inflammatory responses to DNA in the lung
Given its ability to potentiate NF-B activation in cultured 
cells, we sought to assess the role of RAGE in proinflamma-
tory responses to DNA in vivo. Although RAGE has been 
reported to be expressed on several types of mammalian leu-
kocytes (Brett et al., 1993; Dumitriu et al., 2007; Moser et al., 
2007), RAGE is most highly expressed in mammalian lung 
epithelia (Demling et al., 2006; Buckley and Ehrhardt, 2010; 
this study). We therefore hypothesized that RAGE might 
participate in immune recognition of DNA in the airways. 
To address this possibility, we intranasally administered a low 
dose of CpG-B DNA to C57BL/6 wild-type or RAGE defi-
cient (ager/) mice and evaluated inflammatory parameters 
in the lung at 24 h after DNA exposure. Wild-type mice 
mounted a strong inflammatory response to CpG-B DNA, 
characterized by a significant increase in neutrophils in bron-
choalveolar lavage (BAL) fluid, and increased expression of 
the neutrophil chemoattractant LPS-induced CXC chemo-
kine (LIX; Fig. 9 A). Strikingly, RAGE-deficient animals 
showed significantly lower neutrophil influx and LIX levels 
indistinguishable from PBS-treated control animals (Fig. 9 A). 
Histological analysis of lung tissue revealed marked perivas-
cular and peribronchiolar leukocyte influx in wild-type mice 
that was notably reduced in RAGE-deficient mice (Fig. 9 B). 
Analysis of cytokines in the BAL fluid revealed significantly 
reduced production of IFN-g, IL-6, TNF, and IL-12 p70 in 
RAGE-deficient animals as compared with the wild type 
(Fig. 9 C). IL-1 and IFN-a, cytokines whose production is 
not directly activated by NF-B, were also up-regulated in 
wild-type but not RAGE-deficient mice after CpG-B expo-
sure, suggesting a broader role of RAGE in systemic inflam-
mation. When wild-type mice were similarly challenged with 
CpG-A there were notable levels of IFN-a in the airways, 
consistent with the typical TLR9-based response to CpG-A, 
and this effect was significantly attenuated in RAGE deficient 
mice (Fig. 9 D). RAGE deficient mice also showed lower lev-
els of the proinflammatory cytokines IFN-g, IL-12 p70 and 
TNF, compared with wild-type mice (Fig. 9 D). RAGE-induced 
signaling pathways are thought to vary according to cell type 
(Ramasamy et al., 2009) and the mechanisms by which 
RAGE influences the immune response in vivo are likely to 
be complex and multivariate. We note that soluble isoforms of 
RAGE (sRAGE) also exist in vivo (Kalea et al., 2009). We found 
no notable changes in sRAGE levels in wild-type mice after 
Figure 8. RAGE increases TLR9-dependent NF-B activation in 
response to mammalian nucleic acids. (A) HEK293 cells expressing TLR9 
and tetracycline-inducible RAGE-mCerulean ELAM-luc reporter were cul-
tured with or without doxycycline to induce RAGE expression, together 
with murine bone marrow-derived macrophages. Co-cultures were left 
unstimulated or stimulated with silica crystals to induce macrophage cell 
death. Degradation of the phosphodiester (PO) CpG-B DNA stimulus 
served as a positive control for benzonase activity; phosphorothioated 
(PS) DNA is resistant to nuclease digestion and benzonase treatment did 
not affect its ability to activate NF-B through TLR9. Data are shown as 
mean with SEM for triplicate samples and are representative of three 
independent experiments. (B) Co-cultured cells from A were incubated 
with silica for 6 h, stained with propidium iodide to label DNA from dead 
cells, and imaged by confocal microscopy. Silica was visualized using a 
reflection microscopy technique (Hornung et al., 2008). Bars, 5 µm.
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self-derived nucleic acids or DNA sequences that mimic mi-
crobial DNA, and as such, may determine the strength and 
duration of an immune response to nucleic acids.
It has also been proposed that complexes containing mul-
tiple RAGE ligands or RAGE ligated simultaneously with 
other receptors may provide a “symphony” of signals that allow 
the immune system to distinguish between distinct types of 
danger, and to appropriately adjust the immune response to 
nucleic acids (Krieg, 2007). Such synergy between multiple 
1997). Our work characterizes RAGE as a cell surface recep-
tor for nucleic acids that influences the concentration thresh-
old at which DNA activates inflammatory responses in vitro 
and in vivo. This cellular thresholding toward nucleic acids 
may be of importance to carefully balancing the ubiquitous 
presence of self-nucleic acids with the necessity for swift and 
decisive responses toward microbially derived nucleic acids. 
Whether by modulating uptake or by generating a regulatory 
signal, RAGE critically influences cellular responses toward 
Figure 9. RAGE mediates DNA-induced 
pulmonary inflammation in vivo. (A–C) 
C57BL/6 wild-type or RAGE-deficient mice 
were administered PBS with or without 5 µg 
CpG-B via the intranasal route and analyzed 
24 h later for signs of pulmonary inflamma-
tion. n = 6 mice per group. Data shown are 
from one of two independent experiments 
with similar results. (A) Neutrophil cell num-
ber (top), and LIX concentration (bottom) were 
determined in bronchoalveolar lavage fluid. 
(B) Representative hematoxylin and eosin–
stained paraffin sections of lung tissue from 
wild-type and RAGE-deficient (ager/) mice, 
at 10× magnification. Bars, 100 µm. (C) Cyto-
kine concentrations in BAL fluid were deter-
mined by ELISA. (D) C57BL/6 wild-type or 
RAGE-deficient mice were administered PBS 
with or without 50 µg CpG-A (or control  
GpC-A) via the intranasal route and analyzed 
24 h later for signs of pulmonary inflammation.  
n = 8 (PBS, GpC) or 6 (CpG) mice per group. 
Cytokine concentrations in BAL fluid were 
determined by ELISA. (A, C, and D) Data are 
presented as mean with SEM. P-value indi-
cates significance in the nonparametric 
Mann-Whitney U test; ns = differences are 
not significant.
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itself is driven by inflammation, as the gene possesses an 
NF-B–responsive promoter (Li and Schmidt, 1997). Hence, the 
combination of induced receptor expression and appear-
ance of RAGE ligands specifically at times of inflammation 
may serve to lower thresholds and amplify inflammatory re-
sponses in a timely manner. Moreover, the propensity of many 
RAGE ligands to interact with themselves (S100 proteins; 
Ostendorp et al., 2007) or with one another (nucleic acids and 
HMGB1; Tian et al., 2007) to form sizable complexes, appears 
to increase ligand–receptor affinity and allow for simultaneous 
detection of danger signals with nucleic acids released from 
microbes. Thus, RAGE is likely to integrate combinations of 
inflammatory stimuli, and drive appropriately adjusted immune 
responses. The activity of RAGE is also regulated by concen-
tration and metal ion-dependent cis- or trans- homodimer-
ization (Koch et al., 2010; Sárkány et al., 2011) and the soluble 
RAGE form has been shown to interfere with RAGE dimer-
ization and signaling (Hofmann et al., 1999; Bierhaus et al., 
2001). Thus, fine-tuning of RAGE activation is likely an impor-
tant mechanism for timely detection of microbes and sterile 
tissue damage. However, increased autoantibody complex-
ation of nucleic acids and other RAGE ligands during auto-
immune diseases, as well as numerous disease phenotypes linked 
to RAGE in animal models (Yan et al., 2009), suggest that RAGE- 
mediated augmentation of inflammation can be dysregulated 
in immune pathologies and RAGE, therefore, represents an 
attractive target for pharmacological intervention.
MATERIALS AND METHODS
ODNs. ODN sequences and sources are listed in Table S1.
Cell lines. Cell lines in the HEK293, 293T, HeLa, and U373 backgrounds 
were produced using retro- or lentiviral transduction with human RAGE 
C-terminally fused to fluorescent protein tags, as indicated in the text and figure 
legends. We note that, although 293T cells have been reported to express 
RAGE (Zong et al., 2010), no endogenous RAGE expression was detected 
in our HEK293 cell line at the mRNA level before transgene introduction.
Protein expression and purification for AlphaScreen binding studies.  
His-tagged human RAGE extracellular domain and deletion mutants con-
taining the V domain (amino acids 1–121), V-C1 domains (amino acids 1–258), 
or C1-C2 domains (amino acids 122–342) were amplified by PCR and 
cloned into a His-tag–containing plasmid. For the C1-C2 deletion mutant, 
the RAGE leader sequence was added to the constructs by overlapping 
extension PCR. To generate recombinant RAGE deletion mutant proteins, 
expression vectors were transfected into Freestyle 293F cells (Invitrogen) and 
His-tagged proteins were subsequently purified from the cell culture super-
natants using a HisTrap column (GE Healthcare) and a DuoFlow FPLC system 
(Bio-Rad Laboratories). Proteins were eluted from the column in high- 
salt buffer containing 500 mM sodium chloride and 25 mM imidazole, and 
dialyzed against PBS.
Protein expression and purification for structural analysis. Human 
RAGE V-C1 domain (residues 23–237) was expressed in bacteria and purified 
using metal-ion affinity, hydrophobic interaction, and size-exclusion chroma-
tography. The V-C1 domain (Ala23 to Glu237) of human RAGE was cloned 
into a pET30a vector (EMD Biosciences) with a TEV cleavable N-terminal 
GB1 tag. Transformed BL21 (DE3) Codon Plus RIPL cells (Stratagene) were 
grown at 37°C until OD600 reached 1.2. Cells were then induced with 0.2 mM 
IPTG at 18°C for 4 h, harvested, and resuspended in a buffer containing 
RAGE ligands may help to reconcile our observation of a direct 
RAGE–DNA interaction with published data indicating that 
HMGB proteins, also RAGE ligands, are important for TLR 
activation by nucleic acids (Yanai et al., 2009). Our previous 
work suggested that a DNA–HMGB1 complex was more ef-
fective at activating plasmacytoid dendritic cells than HMGB1 
alone (Tian et al., 2007). Judging from the RAGE–DNA 
complex structure presented here, it is clear that HMGB1 is 
not essential for the RAGE–DNA binding event, as DNA 
can directly bind to RAGE in the absence of HMGB1. How-
ever, our data also demonstrate that structured DNAs have 
higher affinities to RAGE, and that these types of DNA in-
duce receptor superclustering. This may alter the rate at which 
they traffic through the endosomal network in complex with 
RAGE. HMGB1 is commonly present in mammalian sera 
and is induced during tissue damage. Thus, in agreement with 
our previous work, DNA complexation by HMGB1 would 
be expected to change the DNA-binding properties to RAGE 
and modify DNA trafficking. Previous work suggests that 
trafficking of nucleic acids is regulated and influenced by both 
the ligand (Honda et al., 2005) and cellular factors (Blasius 
et al., 2010; Sasai et al., 2010). By this logic, HMGB1 may influ-
ence the subcellular site of interaction with the signaling 
receptor, thus altering the relative activation of NF-B and 
type-I interferon signaling pathways downstream of TLR9, a 
hypothesis that remains to be tested. With or without the help 
of cofactors like HMGB1, specificity for distinct nucleic acid 
sequences or structures is a hallmark of many known nucleic 
acid sensors. Unmethylated CpG dinucleotide motifs (Hartmann 
et al., 2000; Hemmi et al., 2000) promote activation of  TLR9, 
and such a CpG sequence preference has also been reported 
for DNA binding to RAGE (Ruan et al., 2010). However, this 
sequence preference appears to be restricted to the nonnative 
form of phosphorothioate backbone, and TLR9 responses to 
the native phosphodiester DNA are sequence-independent 
(Haas et al., 2008). In agreement, our data strongly suggest 
that the DNA–RAGE interaction occurs irrespective of nu-
cleotide sequence, and that RAGE serves to sample any type 
of “naked” extracellular nucleic acid. The RAGE–DNA com-
plex structures illustrate that RAGE interacts with negatively 
charged phosphates of the nucleic acid backbone, and this is 
corroborated by binding of base-free ribose and deoxyribose 
phosphate backbones to RAGE in solution. To our knowl-
edge, this is the first structural analysis of RAGE co-crystallized 
with nucleic acids, and the DNA–RAGE interface supports 
the charge-based binding modality that has been inferred for 
AGE (Park and Boyington, 2010), HMGB1 (Banerjee et al., 
2010), S100b (Koch et al., 2010), and, most recently, heparan 
sulfate (Xu et al., 2013). Thus, RAGE may engage a variety of 
acidic or negatively charged ligands through electrostatic at-
tractions similar to those detailed here.
We note with interest that most characterized RAGE ligands 
are either released during cell stress (S100 proteins, HMGB1, 
and nucleic acids), or generated during prolonged hypergly-
cemia and inflammation (AGE, amyloid , and serum amy-
loid A; Sims et al., 2010). At the same time, RAGE expression 
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the hanging drop vapor diffusion method. The RAGE V-C1–DNA com-
plex was crystallized with a well solution containing 12% PEG6000, and 0.1 M 
Tris-HCl pH 7.4. A solution containing 12% PEG6000, 10% ethylene gly-
col, 10% glycol, and 0.1 M Tris-HCl, pH 7.4, was used as a cryoprotectant 
to freeze crystals in liquid nitrogen before data collection.
X-ray diffraction, structure determination, and refinement. X-ray 
diffraction data were collected at GM/CA-CAT at the Advanced Photon 
Source (APS; Argonne). Data were processed with the HKL200 program 
suite (Otwinowski and Minor, 1997) and XDS (Kabsch, 2010). The RAGE 
V-C1-DNA structures were determined by molecular replacement with 
Phaser (McCoy et al., 2007) from the CCP4 program suite (Potterton et al., 
2003). Previously reported RAGE structures (Koch et al., 2010; Park and 
Boyington, 2010), and ideal dsDNAs from Coot (Emsley and Cowtan, 2004) 
or make_na server (Lakshiminarayanan and Sasisekharan, 1970) were used as 
the initial search models. Structure building and refinement were performed 
with Coot and Phenix (Adams et al., 2010) and are summarized in Table 1. 
The final refined models show no gross structural changes for RAGE upon 
DNA binding. DNA base pair hydrogen bonding restraints were generated 
by the three-dimensional restraints server (Laurberg et al., 2008) and applied 
during refinement. TLS parameters were generated by the TLSMD server 
(Painter and Merritt, 2006) and Phenix (Adams et al., 2010) and applied 
throughout the refinement. Final structural models were validated by the 
Molprobity server (Chen et al., 2010) and RCSB ADIT validation server 
(Yang et al., 2004). Electrostatic charge surfaces were calculated with program 
Delphi (Honig and Nicholls, 1995) and displayed in Pymol (Delano Scien-
tific LLC). The structures and x-ray diffraction data were deposited at the 
RCSB Protein Data Bank with accession codes 3S58 and 3S59.
Fluorescence polarization assay. 5-fluorescein (FAM) labeled 20mer 
DNA oligo ODN 787 (Table S1) was dissolved in 20 mM Tris-HCl, pH 8.0, 
and 100 mM NaCl and annealed with its reverse complement ODN 788. 
Purified RAGE wild-type or mutants were mixed with 3 nM FAM-labeled 
dsDNA and diluted into assay buffers containing 20 mM Hepes-Na, pH 7.4, 
and 100 mM NaCl. The mixtures were then aliquoted in triplets into black 
96-well plates and fluorescence polarization was measured with a Paradigm 
spectrometer (Molecular Devices). Data were analyzed and plotted using 
GraphPad Prism software version 5.0 (GraphPad Software, Inc.). In addition 
to the “mutant 1” containing mutations at site 1 (K37A, K39A, K43A, and 
K107A; Fig. 3 A) and “mutant 2” at site 2 (R29A, Y118A, K123A, and 
R218A), we analyzed DNA binding by an irrelevant mutant (“mutant 0”) 
containing mutations at three basic residues outside of the DNA-binding 
surface (K110A, R178A, and R179A).
Confocal microscopy. Live cells were imaged on glass-bottom culture 
dishes (MatTek) after overnight culture. Images shown represent a single 
z plane though the approximate center of the cells of interest. Images were ob-
tained with an SP2 AOBS laser scanning confocal microscope (Leica) using a 
63× 1.4 NA oil immersion objective (images in Figs. 1 and 6) or a SP5 SMD 
(Leica) using a 63× 1.2 NA water immersion objective (images in Figs. 5 
and 7). Sequential scanning was used to avoid cross excitation between fluo-
rescence channels. Scale bars are approximate.
Förster resonance energy transfer (FRET) measurements. HEK293 
cells coexpressing RAGE-CFP and RAGE-YFP were brought into suspen-
sion and incubated in PBS with the indicated CpG ODN on ice for 20 min. 
After incubation at 37°C for 5 min, the cells were washed with ice-cold PBS 
and kept on ice until flow cytometry FRET analysis was performed as previ-
ously described (Szentesi et al., 2004). RAGE-CFP or RAGE-YFP single 
transfectants were used as controls. Microscopy-based sensitized emission 
FRET was performed using a SP5 SMD confocal microscope. HEK293 cells 
were cultured on glass-bottom dishes and incubated with 10 µg/ml doxycy-
cline for 24 h to express tetracycline-inducible RAGE-mCerulean and 
RAGE-mCitrine alone (as controls) or together. Cells were then treated with 
0.25 µM Alexa Fluor 647–labeled ODN 2006 or 2336 for 15–30 min at 
100 mM NaCl, 5 mM imidazole, and 20 mM Tris-HCl, pH 8.0, supple-
mented with DNase (Biomatik) and protease inhibitors (Roche). Cells were 
lysed by sonication, and soluble protein was purified from cleared cell lysate 
by HisPrep IMAC column (GE Healthcare). Nonspecific DNA contami-
nants were removed by adding ammonium sulfate powder to the IMAC elution 
fractions to a final concentration of 3M. The protein pellet was dissolved in 
a buffer containing 100 mM NaCl and 20 mM Tris-HCl, pH 8.0, before TEV 
protease cleavage of the expression tag. The RAGE V-C1 domain was further 
purified by a second IMAC column, followed by phenyl-Sepharose hydro-
phobic interaction chromatography and size exclusion chromatography.
Binding studies. Binding of biotinylated ODNs to purified, His-tagged, 
human RAGE domains was assayed in a buffer (50 mM Tris-HCl pH 7.4, 
100 mM NaCl, 1% ultrapure BSA, 0.01% Tween 20) using an amplified 
luminescent proximity assay with streptavidin-conjugated donor beads and 
nickel chelate acceptor beads (AlphaScreen; Perkin Elmer; Schlee et al., 2009). 
For cell-binding studies, HeLa cells coexpressing RAGE-CFP and Rab4a-YFP 
or expressing only Rab4a-YFP were incubated with 1 µM Alexa Fluor 647–
labeled ODN 2336 at 37°C for 5 min, washed with medium, and imaged by 
confocal microscopy. 293T cells expressing tetracycline-inducible RAGE-
mCitrine were tetracycline-induced for 24 h or left untreated, and then in-
cubated with 1 µM Alexa Fluor 647–labeled ODN 2336 on ice for 30 min. 
Cells were washed with PBS and analyzed on a BD LSR II instrument (Becton 
Dickinson) using FACSDiva (BD) and FlowJo software (Tree Star). For co-
immunoprecipitation of TLR9 and RAGE, U373 glioma epithelial cells vi-
rally transduced with the indicated proteins were incubated for 1 h with 1 µM 
ODN 2006 or with culture medium only. Cells were lysed and incubated 
with protein A–coated Dynabeads (Invitrogen) and rabbit polyclonal anti-
GFP antibody (Invitrogen). Proteins captured on the beads were resolved by 
SDS-PAGE and TLR9 and RAGE were detected by immunoblotting.
DNA uptake studies. HEK293 cells (Fig. 6) expressing tetracycline-inducible 
RAGE-mCitrine were induced with 1 µg/ml tetracycline overnight or left 
untreated, and then incubated with Alexa Fluor 647–labeled ODN 2006, 
ODN 2336, or transferrin for 30 min as indicated and, after PBS washes, ana-
lyzed on a LSRII instrument (BD) using FACSDiva (BD) and FlowJo soft-
ware (Tree Star). HeLa RAGE-CFP cells coexpressing either Rab5a-RFP or 
Rab9a-YFP were cultured on glass-bottom dishes (MatTek) pulsed with 
500 nM Alexa Fluor 647–labeled ODN in medium for 5 min at 37°C, washed 
with PBS, and then incubated in medium for the indicated time periods be-
fore imaging by confocal microscopy as detailed below. Channel line analyses 
were done using Volocity software (PerkinElmer). 293T cells (Fig. 7) were 
induced with 500 ng/ml doxycycline overnight or left untreated, and then 
incubated with Alexa Fluor 647–labeled ODN 2006 or 2336 at 37°C for 
the indicated times. Excess oligonucleotides were removed by washing and 
cells were analyzed by flow cytometry as mentioned above. For imaging, 
293T cells expressing tetracycline-inducible RAGE-mCitrine or RAGE-dC-
mCitrine (Fig. 7) were treated for 24 h with 10 ng/ml doxycycline, washed, 
and subsequently stimulated with 250 nM ODN 2336. Images were acquired 
by confocal microscopy as detailed below.
Crystallization of the RAGE–DNA complex. DNA oligos were syn-
thesized by IDT without a 5-phosphate. dsDNA with different sequences 
and lengths were tested in co-crystallization with the RAGE V-C1 domain. 
The two 22mer dsDNA oligos used in the current crystal structures were 
derived from vaccinia virus genomic repeat sequences (annealed from 
5-CCATGACTGTAGGAAACTCTAG-3 and 5-GCTAGAGTTTCCT-
ACAGTCATG-3) and CpG sequences (annealed from 5-CTGCAAC-
GATGCTACGAACGTG-3 and 5-CACGTTCGTAGCATCGTTG-
CAG-3). Oligos were dissolved in a buffer containing 100 mM KCl, 5 mM 
DTT, 20 mM Hepes, pH 7.4. Complementary oligos were mixed at a 1:1 
molar ratio, heated to 95°C, and annealed by slow cooling to room tempera-
ture. Annealed dsDNAs were added to diluted protein solutions (1 mg/ml), 
and the protein–DNA complexes were concentrated with centrifugal con-
centrators (Millipore) to 10–20 mg/ml before setting up crystallization using 
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